RANI compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

KLRSKalaris Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RANIRani Therapeutics Holdings, Inc.

KLRSKalaris Therapeutics, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

RANI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.6%▼−0.23%×0.01

KLRS1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.76%—

= impliedRANI realized, solidKLRS realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

RANIRani Therapeutics Holdings, Inc.

0.60▼−1.49%· post 0.60

Mkt cap$82.2MRevenue$2MQ2 FY26

KLRSKalaris Therapeutics, Inc.

2.00▼−6.10%· post 2.04

ClosedOct 30 '26

Mkt cap$48.3MRevenue—

Compare

ClosedOct 30 '26

RANIRani Therapeutics Holdings, Inc.

KLRSKalaris Therapeutics, Inc.

0.60▼−1.49%post 0.60

Price

2.00▼−6.10%post 2.04

$82.2M

Mkt cap

$48.3M

Q2 FY26$2M

Revenue

—

RANI0.60▼−1.49%vsKLRS2.00▼−6.10%ClosedOct 30 '26